The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits. 2014

Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznań, Poland. Electronic address: agnbienert@op.pl.

BACKGROUND This study evaluates the time-of-day effect on midazolam and 1-OH midazolam pharmacokinetics, and on the sedative pharmacodynamic response in rabbits. Also, circadian fluctuations in rabbits' vital signs, such as the blood pressure, heart rate and body temperature were examined. The water intake was measured in order to confirm the presence of the animals' diurnal activity. The secondary aim involved the comparison of two methods of data analysis: a noncompartmental and a population modeling approach. METHODS Twelve rabbits were sedated with intravenous midazolam 0.35 mg/kg at four local times: 09.00, 14.00, 18.00 and 22.00 h. Each rabbit served as its own control by being given a single infusion at the four different times of the day on four separate occasions. The values of the monitored physiological parameters were recorded during the experiment and arterial blood samples were collected for midazolam assay. The pedal withdrawal reflex was used as the measurement of the sedation response. Two and one compartmental models were successfully used to describe midazolam and 1-OH midazolam pharmacokinetics. The categorical pharmacodynamic data were described with a logistic model. CONCLUSIONS We did not find any time-of-day effects for the pharmacokinetic and pharmacodynamics parameters of midazolam. For 1-OH midazolam, statistically significant time-of-day differences in the apparent volume of distribution and clearance were noticed. They corresponded well with the rabbits' water intake. The noncompartmental and model-based parameters were essentially similar. However, more information can be obtained from the population model and this method should be preferred in chronopharmacokinetic and chronopharmacodynamic studies.

UI MeSH Term Description Entries
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051544 Cytochrome P-450 CYP3A A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN. CYP3A,CYP3A4,CYP3A5,Cytochrome P-450 CYP3A4,Cytochrome P-450 CYP3A5,Cytochrome P-450IIIA,Cytochrome P450 3A,Cytochrome P450 3A4,Cytochrome P450 3A5,Erythromycin N-Demethylase,Taurochenodeoxycholate 6-alpha-Monooxygenase,3A5, Cytochrome P450,6-alpha-Monooxygenase, Taurochenodeoxycholate,Cytochrome P 450 CYP3A,Cytochrome P 450 CYP3A4,Cytochrome P 450 CYP3A5,Cytochrome P 450IIIA,Erythromycin N Demethylase,N-Demethylase, Erythromycin,P-450 CYP3A, Cytochrome,P-450 CYP3A4, Cytochrome,P-450 CYP3A5, Cytochrome,P-450IIIA, Cytochrome,P450 3A, Cytochrome,P450 3A5, Cytochrome,Taurochenodeoxycholate 6 alpha Monooxygenase

Related Publications

Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
January 2002, Polish journal of pharmacology,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
February 1996, Arzneimittel-Forschung,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
January 2018, PeerJ,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
October 2006, Molecular and cellular biochemistry,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
June 2010, British journal of clinical pharmacology,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
June 1999, Clinical pharmacology and therapeutics,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
October 2007, Clinical pharmacology and therapeutics,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
August 2014, European review for medical and pharmacological sciences,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
August 1985, Anesthesiology,
Agnieszka Bienert, and Włodzimierz Płotek, and Paweł Wiczling, and Bartosz Kostrzewski, and Agnieszka Kamińska, and Hanna Billert, and Damian Szczesny, and Czesław Zaba, and Artur Teżyk, and Katarzyna Buda, and Ewa Bednarek, and Roman Kaliszan, and Edmund Grześkowiak
January 1998, Life sciences,
Copied contents to your clipboard!